
Sign up to save your podcasts
Or


This week on Lunch Money, Brooke Roberts (Sharesies' co-founder) and Alice Rountree (Sharesies' Financial Analyst) chat to Brian Ward, CEO of ASX-listed company Aroa Biosurgery—a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products. Brian takes us through Aroa's business model, and reflects on Aroa's journey to becoming an ASX-listed company.
See omnystudio.com/listener for privacy information.
By Sharesies5
33 ratings
This week on Lunch Money, Brooke Roberts (Sharesies' co-founder) and Alice Rountree (Sharesies' Financial Analyst) chat to Brian Ward, CEO of ASX-listed company Aroa Biosurgery—a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products. Brian takes us through Aroa's business model, and reflects on Aroa's journey to becoming an ASX-listed company.
See omnystudio.com/listener for privacy information.

16,174 Listeners

22 Listeners

8,876 Listeners

3,903 Listeners

61 Listeners

362 Listeners

24 Listeners

127 Listeners

575 Listeners

15 Listeners

14 Listeners

85 Listeners

2,131 Listeners

602 Listeners

16 Listeners